AlphaCrest Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,238
| Closed | -$577K | – | 743 |
|
|
2022
Q3 | $577K | Buy |
+30,238
| New | +$577K | 0.04% | 914 |
|
|
2022
Q2 | – | Sell |
-14,792
| Closed | -$373K | – | 1322 |
|
|
2022
Q1 | $373K | Sell |
14,792
-19,497
| -57% | -$492K | 0.02% | 1028 |
|
|
2021
Q4 | $946K | Buy |
34,289
+11,570
| +51% | +$319K | 0.04% | 822 |
|
|
2021
Q3 | $734K | Sell |
22,719
-14,067
| -38% | -$454K | 0.04% | 754 |
|
|
2021
Q2 | $1.13M | Buy |
36,786
+25,775
| +234% | +$788K | 0.05% | 608 |
|
|
2021
Q1 | $335K | Buy |
+11,011
| New | +$335K | 0.02% | 973 |
|
|
2020
Q4 | – | Sell |
-17,152
| Closed | -$224K | – | 1220 |
|
|
2020
Q3 | $224K | Buy |
17,152
+6,874
| +67% | +$89.8K | 0.02% | 999 |
|
|
2020
Q2 | $117K | Buy |
+10,278
| New | +$117K | 0.02% | 876 |
|
|
2019
Q3 | – | Sell |
-8,712
| Closed | -$242K | – | 1301 |
|
|
2019
Q2 | $242K | Buy |
+8,712
| New | +$242K | 0.02% | 924 |
|
|
2019
Q1 | – | Sell |
-9,300
| Closed | -$270K | – | 915 |
|
|
2018
Q4 | $270K | Buy |
+9,300
| New | +$270K | 0.08% | 495 |
|